Initial experience with the novel BioMime 60mm-long sirolimus-eluting tapered stent system in long coronary lesions.

To describe our initial experience with the novel BioMime™ 60mm-long sirolimus-eluting tapered coronary stent system in patients with long coronary lesions.We included 50 consecutive patients in whom a 60mm-long drug- eluting stent (DES) implantation was attempted due to the presence of coronary lesions longer than 48mm. The 60mm-long DES was successfully implanted in 46 (92%) patients. In 4 patients stent deployment failed due to the impossibility of crossing completely the lesions. During a median follow-up of 275 days [IQR (166-386)], no clinical adverse events (death, myocardial infarction or target lesion revascularization) were observed.The use of the novel BioMime™ 60mm-long DES for the treatment of long coronary lesions exhibits promising results in a relatively short-intermediate follow-up.